Skip to main content

BARCLAYS PLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in CMPX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,179,316
+$985,369 QoQ
Shares Held
790,041
+32.8% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Derivatives in CMPX

reported options exposure · as of Mar 31, 2026
CallValue
$1,095,559
CallShares
207,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. CMPX ranks #45 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CMPX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,095,559 207,100
2026-03-31 $4,179,316 790,041
2025-12-31 $3,193,947 594,776
2025-09-30 $778,463 222,418
2025-06-30 $628,474 241,721
2025-03-31 $225,588 118,731
2024-12-31 $279,510 192,766
2024-09-30 $313,250 170,245
2024-06-30 $57,631 57,631
2024-03-31 $150,307 75,913
2023-12-31 $195,758 125,486
2023-09-30 $59,696 30,303
2023-06-30 $101,508 31,921
2023-03-31 $134,023 40,986
2022-12-31 $91,670 18,225
2022-09-30 $852 374